Frequency News and Research

RSS

Simple, personalized interventions improve colorectal cancer screening rates

Different types of personalized interventions can improve colorectal cancer (CRC) screening rates in primary care practices, according to a new study.

25 Sep 2007

New study likely to fuel debate over annual physical exams

While most patients and physicians believe it's important for adults to have an annual physical exam, there's growing debate about this conventional wisdom.

25 Sep 2007

Genetic influences on addictions - new findings

Previous research has extensively studied the association of the dopamine D2 receptor gene (DRD2) with alcoholism.

25 Sep 2007

Trop-2 new target for anti-tumour therapy in cancer

Italian scientists announced (Monday September 24) that they have found a new and promising target for anti-tumour therapy in cancer.

25 Sep 2007

WHO and its partners call for increased research to improve patient safety

They emphasized the need for intensified research at an international conference that opened today in Porto, Portugal. The conference on Patient safety research: shaping the European agenda will examine evidence showing that harm from medical care poses a substantial burden in terms of suffering and death in Europe and around the world.

25 Sep 2007

The cost and value of that annual preventative health check up

Even though as many as an estimated 63.5 million American adults visit their doctor for a preventive health or gynecological examination each year, the value of such visits is a controversial issue.

24 Sep 2007

Infections caused by ESBL-producing E. coli

In light of increased media and public interest in ESBL-producing E. coli, the UK's Health Protection Agency felt it would be helpful to provide some background about these infections and the work that is being carried out in this area.

24 Sep 2007

Top five prescribed drugs

With a total nearly $5 billion, Lipitor, a cholesterol-reducing drug, ranked first in terms of total spending on prescription medicines by adults ages 18 to 64 in 2004, and another cholesterol-fighting drug, Zocor, ranked fourth at $2.3 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Sep 2007

Selective attention increases both gain and feature selectivity of the human auditory cortex

On Sept. 19, a research report by Helsinki University of Technology, Laboratory of Computational Engineering scientists will appear in the online, open-access journal PLoS ONE, showing that selective attention increases both gain and feature selectivity of the human auditory cortex.

20 Sep 2007

Long-term cell phone use may cause inner ear damage

Hold the phone – long-term use of a cell phone may cause inner ear damage and can lead to high frequency hearing loss, according to a new study.

20 Sep 2007

Grapheme-color synaesthesia

A psychological phenomenon known as "grapheme-color synaesthesia" describes individuals who experience vivid colors whenever they see, hear, or think of ordinary letters and digits.

18 Sep 2007

Study examines implications of genetic screening for disease that can be less serious, treatable

Some couples in Israel whose fetus screened positive for Gaucher disease, which can range from being mild and treatable to being a severe disease, decided to have the pregnancy terminated, raising questions concerning the appropriateness of certain types of genetic screenings, according to a study in the September 19 issue of JAMA.

18 Sep 2007

RFID implant cancer questions concern patients

News that radio frequency identification (RFID) implants could pose dangerous health risks -- even cancer -- has the healthcare and personal health records (PHR) industries wondering how to provide medical professionals with vital patient health records in case of emergency.

18 Sep 2007

Review of antimicrobials for acute rhinosinusitis

Acute bacterial rhinosinusitis in adults is a common malady, with between 30 to 35 million cases a year.

18 Sep 2007

Gene profiling can single out the worst cases of multiple myeloma and guide therapy

Multiple myeloma patients vary widely in how they respond to treatment, but now researchers at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences have identified a small subset of genes whose activity could predict high-risk cases and potentially guide therapy in the future.

18 Sep 2007

FDA accepts Sucampo's sNDA for Lubiprostone for the treatment of irritable bowel syndrome

Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).

18 Sep 2007